Cargando…
Clinical impact of nasal budesonide treatment on COPD patients with coexistent rhinitis
BACKGROUND: A high percentage of patients with COPD report chronic nasal symptoms. The study aims to evaluate the clinical impact of a 2-month treatment with inhaled nasal budesonide (100 µg per nostril twice daily) in patients affected by COPD with chronic rhinitis comorbidity. PATIENTS AND METHODS...
Autores principales: | Calabrese, Cecilia, Costigliola, Adriano, Maffei, Marianna, Simeon, Vittorio, Perna, Francesco, Tremante, Eugenio, Merola, Elena, Leone, Carlo Antonio, Bianco, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029594/ https://www.ncbi.nlm.nih.gov/pubmed/29988687 http://dx.doi.org/10.2147/COPD.S165857 |
Ejemplares similares
-
The Effectiveness of Budesonide Nasal Irrigation in Patients with Allergic Rhinitis
por: Ishak, Muhammad Nu’aim, et al.
Publicado: (2022) -
Fast effectiveness of a solubilized low‐dose budesonide nasal spray in allergic rhinitis
por: Zieglmayer, Petra, et al.
Publicado: (2020) -
Azelastine and budesonide (nasal sprays): Effect of combination therapy monitored by acoustic rhinometry and clinical symptom score in the treatment of allergic rhinitis
por: Fabbri, Natalia Zanellato, et al.
Publicado: (2014) -
Budesonide–formoterol (inhalation powder) in the treatment of COPD
por: Ceylan, Erkan
Publicado: (2006) -
Budesonide/Glycopyrronium/Formoterol: A Review in COPD
por: Heo, Young-A
Publicado: (2021)